Wim Van Molle
About
In The Last Decade
Wim Van Molle
20 papers receiving 891 citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 392
- Immunology 239
- Genetics 142
- Cancer Research 125
- Epidemiology 120
Countries citing papers authored by Wim Van Molle
This map shows the geographic impact of Wim Van Molle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim Van Molle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim Van Molle more than expected).
Fields of papers citing papers by Wim Van Molle
This network shows the impact of papers produced by Wim Van Molle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim Van Molle. The network helps show where Wim Van Molle may publish in the future.
Co-authorship network of co-authors of Wim Van Molle
This figure shows the co-authorship network connecting the top 25 collaborators of Wim Van Molle. A scholar is included among the top collaborators of Wim Van Molle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim Van Molle. Wim Van Molle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 30 | |
| 3 | 215 | |
| 4 | 16 | |
| 5 | 3 | |
| 6 | 20 | |
| 7 | 164 | |
| 8 | 6 | |
| 9 | 2 | |
| 10 | 78 | |
| 11 | 50 | |
| 12 | 13 | |
| 13 | 14 | |
| 14 | 8 | |
| 15 | 11 | |
| 16 | 68 | |
| 17 | 101 | |
| 18 | 1 | |
| 19 | 89 | |
| 20 | Receptor-selective mutants of tumour necrosis factor in the therapy of cancer: preclinical studies. | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.